品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
源叶 | S81017-100mg | 100mg | 厂家现货 | 856925-71-8 |
Tedizolid Tedizolid |
98% |
|
|
源叶 | S81019-5mg | 5mg | 厂家现货 | 856925-71-8 |
(-)-Blebbistatin (-)-Blebbistatin |
99% |
|
|
源叶 | S81019-25mg | 25mg | 厂家现货 | 856925-71-8 |
(-)-Blebbistatin (-)-Blebbistatin |
99% |
|
|
源叶 | S81019-10mg | 10mg | 厂家现货 | 856925-71-8 |
(-)-Blebbistatin (-)-Blebbistatin |
99% |
|
|
索莱宝 | YS100205-250mg | 250mg | 厂家现货 | 856925-71-8 |
(S)-3a-羟基-6-甲基-1-苯基-3,3a-二氢-... (-)-Blebbistatin |
98% |
|
|
索莱宝 | YS100205-50mg | 50mg | 厂家现货 | 856925-71-8 |
(S)-3a-羟基-6-甲基-1-苯基-3,3a-二氢-... (-)-Blebbistatin |
98% |
|
|
索莱宝 | YS100205-100mg | 100mg | 厂家现货 | 856925-71-8 |
(S)-3a-羟基-6-甲基-1-苯基-3,3a-二氢-... (-)-Blebbistatin |
98% |
|
|
阿拉丁 | B129580-10mg | 10mg | 期货,请咨询 | 856925-71-8 |
(−)-布雷他汀 (-)-Blebbistatin |
≥98% |
|
|
阿拉丁 | B129580-50mg | 50mg | 现货 | 856925-71-8 |
(−)-布雷他汀 (-)-Blebbistatin |
≥98% |
|
|
阿拉丁 | B129580-5mg | 5mg | 现货 | 856925-71-8 |
(−)-布雷他汀 (-)-Blebbistatin |
≥98% |
|
|
阿拉丁 | B129580-1mg | 1mg | 现货 | 856925-71-8 |
(−)-布雷他汀 (-)-Blebbistatin |
≥98% |
|
|
阿拉丁 | B408138-1ml | 1ml | 期货,请咨询 | 856925-71-8 |
(-)-Blebbistatin (-)-Blebbistatin |
10mM in DMSO |
|
|
阿拉丁 | B129580-100mg | 100mg | 现货 | 856925-71-8 |
(−)-布雷他汀 (-)-Blebbistatin |
≥98% |
|
|
阿拉丁 | B129580-250mg | 250mg | 期货,请咨询 | 856925-71-8 |
(−)-布雷他汀 (-)-Blebbistatin |
≥98% |
|
|
阿拉丁 | B129580-25mg | 25mg | 现货 | 856925-71-8 |
(−)-布雷他汀 (-)-Blebbistatin |
≥98% |
|
|
麦克林 | B873251-1mg | 1mg | 厂家现货 | 856925-71-8 |
(-)-Blebbistatin (-)-Blebbistatin |
99% |
|
|
麦克林 | B873251-5mg | 5mg | 厂家现货 | 856925-71-8 |
(-)-Blebbistatin (-)-Blebbistatin |
99% |
|
|
毕得 | BD559087-1mg | 1mg | 现货 | 856925-71-8 |
(S)-3a-羟基-6-甲基-1-苯基-3,3a-二氢-... (S)-3a-Hydroxy-6-methyl-1-ph... |
98% |
|
|
毕得 | BD559087-5mg | 5mg | 现货 | 856925-71-8 |
(S)-3a-羟基-6-甲基-1-苯基-3,3a-二氢-... (S)-3a-Hydroxy-6-methyl-1-ph... |
98% |
|
|
毕得 | BD559087-10mg | 10mg | 现货 | 856925-71-8 |
(S)-3a-羟基-6-甲基-1-苯基-3,3a-二氢-... (S)-3a-Hydroxy-6-methyl-1-ph... |
98% |
|
|